Accession | Acc. Gene-, Name | Start | End | Subsequence | Logic | PDB | Organism | Length |
---|---|---|---|---|---|---|---|---|
ELMI002627 | P10071 GLI3 GLI3_HUMAN |
333 | 340 | SSSASGSYGHLSASAISPAL | TP |
4BLD |
Homo sapiens (Human) | 1580 |
Instance evidence
Evidence class | PSI-MI | Method | BioSource | PubMed | Logic | Reliability | Notes |
---|---|---|---|---|---|---|---|
experimental | MI:0114 | x-ray crystallography | in vitro | Cherry,2013 | support | certain | InteractionDetection FeatureDetection |
Interactions
Uniprot Id | Domain family | Domain Start | Domain End | Affinity Min/Max (µMol) | Notes |
---|---|---|---|---|---|
(Q9UMX1) SUFU_HUMAN | PF05076
(SUFU)
Suppressor of fused protein (SUFU) |
63 | 242 | [mitab][xml] | |
(Q9UMX1) SUFU_HUMAN | PF12470
(SUFU_C)
Suppressor of Fused Gli/Ci N terminal binding domain |
252 | 473 | [mitab][xml] |
Pathways
KEGG: The sequence P10071 is implicated in the following 4 Pathways: (color codes: This sequence=red, interacting sequence=orange)
Please cite:
The Eukaryotic Linear Motif resource: 2022 release.
(PMID:34718738)
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement